413 related articles for article (PubMed ID: 29037975)
21. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
22. Identification and utility of innate immune system evasion mechanisms of ASFV.
Correia S; Ventura S; Parkhouse RM
Virus Res; 2013 Apr; 173(1):87-100. PubMed ID: 23165138
[TBL] [Abstract][Full Text] [Related]
23. Identification of Novel Inhibitors of the Type I Interferon Induction Pathway Using Cell-Based High-Throughput Screening.
Gage ZO; Vasou A; Gray DW; Randall RE; Adamson CS
J Biomol Screen; 2016 Oct; 21(9):978-88. PubMed ID: 27358388
[TBL] [Abstract][Full Text] [Related]
24. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses.
Guo F; Zhao X; Gill T; Zhou Y; Campagna M; Wang L; Liu F; Zhang P; DiPaolo L; Du Y; Xu X; Jiang D; Wei L; Cuconati A; Block TM; Guo JT; Chang J
Antiviral Res; 2014 Jul; 107():56-65. PubMed ID: 24792753
[TBL] [Abstract][Full Text] [Related]
25. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
Fanunza E; Frau A; Sgarbanti M; Orsatti R; Corona A; Tramontano E
Viruses; 2018 Feb; 10(2):. PubMed ID: 29495311
[TBL] [Abstract][Full Text] [Related]
27. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.
Ning YJ; Feng K; Min YQ; Cao WC; Wang M; Deng F; Hu Z; Wang H
J Virol; 2015 Apr; 89(8):4227-36. PubMed ID: 25631085
[TBL] [Abstract][Full Text] [Related]
28. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I.
Ling Z; Tran KC; Teng MN
J Virol; 2009 Apr; 83(8):3734-42. PubMed ID: 19193793
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
30. Construction and Characterization of a Recombinant Human Respiratory Syncytial Virus Encoding Enhanced Green Fluorescence Protein for Antiviral Drug Screening Assay.
Xu M; Jiao YY; Fu YH; Jiang N; Zheng YB; Yan YF; Zhang M; Zheng YP; Zhu WY; Peng XL; He JS
Biomed Res Int; 2018; 2018():8431243. PubMed ID: 29568767
[TBL] [Abstract][Full Text] [Related]
31. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of the interferon response enhance virus replication in vitro.
Stewart CE; Randall RE; Adamson CS
PLoS One; 2014; 9(11):e112014. PubMed ID: 25390891
[TBL] [Abstract][Full Text] [Related]
33. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
34. High-throughput screening normalized to biological response: application to antiviral drug discovery.
Patel DA; Patel AC; Nolan WC; Huang G; Romero AG; Charlton N; Agapov E; Zhang Y; Holtzman MJ
J Biomol Screen; 2014 Jan; 19(1):119-30. PubMed ID: 23860224
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.
Liu P; Jamaluddin M; Li K; Garofalo RP; Casola A; Brasier AR
J Virol; 2007 Feb; 81(3):1401-11. PubMed ID: 17108032
[TBL] [Abstract][Full Text] [Related]
36. STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
Le-Trilling VTK; Wohlgemuth K; Rückborn MU; Jagnjic A; Maaßen F; Timmer L; Katschinski B; Trilling M
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743368
[TBL] [Abstract][Full Text] [Related]
37. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.
Ramaswamy M; Shi L; Monick MM; Hunninghake GW; Look DC
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):893-900. PubMed ID: 14722224
[TBL] [Abstract][Full Text] [Related]
39. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.
Li JQ; Deng CL; Gu D; Li X; Shi L; He J; Zhang QY; Zhang B; Ye HQ
Antiviral Res; 2018 Feb; 150():148-154. PubMed ID: 29288699
[TBL] [Abstract][Full Text] [Related]
40. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
